Abstract
G-protein coupled receptors (GPCRs) are proteins of the plasma membrane, which are characterized by seven membrane-spanning segments (TMs). GPCRs play an important role in almost all of our physiological and pathophysiological conditions by interacting with a large variety of ligands and stimulating different G-proteins and signaling cascades. By playing a key role in the function of our body and being involved in the pathophysiology of many disorders, GPCRs are very important therapeutic targets. Determination of the structure and function of GPCRs could advance the design of novel receptor-specific drugs against various diseases. A powerful method to obtain structural and functional information for GPCRs is the cysteine substituted accessibility method (SCAM). SCAM is used to systematically map the TM residues of GPCRs and determine their functional role. SCAM can also be used to determine differences in the structures of the TMs in different functional states of GPCRs.
Keywords: Binding-site crevice, cysteine substituted accessibility method, function, G-protein coupled receptors, methanothiosulfonate reagents, structure.
Current Pharmaceutical Biotechnology
Title:Obtaining Structural and Functional Information for GPCRs Using the Substituted-Cysteine Accessibility Method (SCAM)
Volume: 15 Issue: 10
Author(s): George Liapakis
Affiliation:
Keywords: Binding-site crevice, cysteine substituted accessibility method, function, G-protein coupled receptors, methanothiosulfonate reagents, structure.
Abstract: G-protein coupled receptors (GPCRs) are proteins of the plasma membrane, which are characterized by seven membrane-spanning segments (TMs). GPCRs play an important role in almost all of our physiological and pathophysiological conditions by interacting with a large variety of ligands and stimulating different G-proteins and signaling cascades. By playing a key role in the function of our body and being involved in the pathophysiology of many disorders, GPCRs are very important therapeutic targets. Determination of the structure and function of GPCRs could advance the design of novel receptor-specific drugs against various diseases. A powerful method to obtain structural and functional information for GPCRs is the cysteine substituted accessibility method (SCAM). SCAM is used to systematically map the TM residues of GPCRs and determine their functional role. SCAM can also be used to determine differences in the structures of the TMs in different functional states of GPCRs.
Export Options
About this article
Cite this article as:
Liapakis George, Obtaining Structural and Functional Information for GPCRs Using the Substituted-Cysteine Accessibility Method (SCAM), Current Pharmaceutical Biotechnology 2014; 15 (10) . https://dx.doi.org/10.2174/1389201015666141020154116
DOI https://dx.doi.org/10.2174/1389201015666141020154116 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Zebrafish as a Novel Tool for Cardiovascular Drug Discovery
Recent Patents on Cardiovascular Drug Discovery Dopamine and the Diseased Brain
CNS & Neurological Disorders - Drug Targets Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Glaucoma Disease: A Survey
Current Medical Imaging Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy
Current Pharmaceutical Design Genes Involved in Hereditary Hearing Impairment
Current Genomics Relative Hypermetabolism of Vermis Cerebelli in Traumatic Brain Injured Patients Studied with 18FDG PET: A Descriptor of Brain Damage and a Possible Predictor of Outcome
Current Radiopharmaceuticals Following Intracellular Cholesterol Transport by Linear and Non-Linear Optical Microscopy of Intrinsically Fluorescent Sterols
Current Pharmaceutical Biotechnology Biological Signatures of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide
Protein & Peptide Letters Orofacial Pain and Mastication in Dementia
Current Alzheimer Research Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson’s Disease
Current Drug Targets Structures of Immunophilins and their Ligand Complexes
Current Topics in Medicinal Chemistry Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor
Medicinal Chemistry Gastrointestinal Motility and Acute Toxicity of Pistagremic Acid Isolated from the Galls of Pistacia integerrima
Medicinal Chemistry Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development
Recent Patents on Biomarkers Gastroesophageal Reflux Disease (GERD): Current Agents and Future Perspective
Current Pharmaceutical Design Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Hyaluronic Acid/Parecoxib-Loaded PLGA Microspheres for Therapy of Temporomandibular Disorders
Current Drug Delivery Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)